News 15 mai 2024 Allegria Therapeutics raises 3.5 million dollars in seed financing round Allegria Therapeutics has received seed funding of 3.5 million dollars from the founding investor Forty51 Ventures. The biotech startup is develo...
News 10 mai 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Aktuell 15 mai 2024 Allegria Therapeutics nimmt 3,5 Millionen Dollar in Seed-Runde ein Allegria Therapeutics hat eine Seed-Finanzierung von 3,5 Millionen Dollar durch den Gründungsinvestor Forty51 Ventures erhalten. Das Biotech-Star...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita
News 01 mar 2024 Idorsia enters collaboration with Viatris The biotech company Idorsia from the canton of Basel-Landschaft and the North American pharmaceutical company Viatris are collaborating on the de...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...